Leonardo Roever: CHR as a Composite Biomarker for Stroke Risk Stratification
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Wei Huang et al, published in Lipids in Health and Disease:
”Association of C-reactive protein/HDL cholesterol ratio with stroke in Chinese adults with different glycemic levels
Stroke is one of the major public health problems in China, highlighting the need for accessible biomarkers to aid in risk stratification.
The C-reactive protein/HDL cholesterol (CHR) ratio, which integrates inflammatory and lipid pathways, has emerged as a new composite biomarker.
Higher CHR levels were associated with an increased risk of stroke in Chinese adults, with heterogeneity between different glycemic levels, showing stronger and nonlinear (J-shaped) associations in individuals with normal blood glucose than in individuals with diabetes.
CHR has demonstrated limited discriminatory ability for stroke, suggesting that its usefulness may lie in risk stratification rather than isolated prediction.
Follow me for more content on evidence, management, and innovation in health
Enroll now in the courses offered by the Brazilian Evidence-Based Health Network and take your research and scientific knowledge to the next level.”
Title: Association of C-reactive protein/high-density lipoprotein cholesterol ratio with stroke in Chinese adults across different glycemic status
Authors: Wei Huang, Jun Gu, Xueli Sun, Zhimei Shen, Qin Yin, Xu Wang
Read the Full Article on BMC/Lipids in Health and Disease
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 21:57Farhad Moradpour: Health Equity and Public Health – What Drives Anemia Disparities in Ethnic Minority Populations?
-
Oct 6, 2026, 21:47Yahya Tawfik: Rising Iron Deficiency in the US – 10 Million More Adults Affected Since 1999
-
Oct 6, 2026, 16:43Beth Shirley: Xylitol Consumption Increases Platelet Reactivity and Cardiovascular Risk
-
Oct 6, 2026, 16:37Jared Rice: What Sets the Transfusion Threshold in Anemia of Prematurity?
-
Oct 6, 2026, 16:30Thirunavukkarasu Angappan: Immunoglobulin Decides How Much Plasma Gets Collected
-
Oct 6, 2026, 16:18Gemma Davies: New CMML Research Selected for Presentation at the 68th ASH Annual Meeting
-
Oct 6, 2026, 16:03Professor Csongor Kiss Receives the Kálmán Laki Prize – Hungarian Society of Thrombosis and Haemostasis
-
Oct 6, 2026, 15:52Mark Kheifets: A Massive Stent Thrombosis Requiring Aspiration Thrombectomy
-
Oct 6, 2026, 15:40Joseph Aslan։ Targeting Mitochondrial Permeability Transition To Reduce Platelet Thrombogenicity